首页> 外文期刊>Herz >Comorbidity, hypoglycaemia and appropriate selection of antidiabetic pharmacotherapy in diabetic patients with heart failure in clinical practice in Germany
【24h】

Comorbidity, hypoglycaemia and appropriate selection of antidiabetic pharmacotherapy in diabetic patients with heart failure in clinical practice in Germany

机译:德国糖尿病合并心力衰竭患者的合并症,低血糖症和适当的抗糖尿病药物治疗选择

获取原文
获取原文并翻译 | 示例
           

摘要

Patients with type 2 diabetes and heart failure are considered to be at high risk for hypoglycaemic complications. There is a considerable uncertainty with respect to the appropriate choice of antidiabetic pharmacotherapy in patients with type 2 diabetes and comorbid heart failure. Little is known about comorbidity, hypoglycaemia rates and selected pharmacotherapy in diabetic patients with heart failure in clinical practice.
机译:2型糖尿病和心力衰竭患者被认为存在降血糖并发症的高风险。对于2型糖尿病合并合并心力衰竭的患者,适当选择抗糖尿病药物治疗存在很大的不确定性。在临床实践中,对合并糖尿病,心力衰竭的糖尿病患者的合并症,低血糖发生率和选择的药物治疗知之甚少。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号